Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Biotechnology

Health Care

Haystack Oncology

Dan Edelstein

Joshua Cohen

Tweed Hanusek

Matt Ryder

Joel Kaufman

Jared Snider, Ph.D.

Hannah Quinn

Frank Holtrup

The Leadership Team at Haystack Oncology drives the company’s strategic vision and operational excellence in advancing cutting-edge circulating tumor DNA detection technologies. Comprising key executives with expertise in innovation, finance, technology, and management, the team focuses on enhancing diagnostic capabilities for minimum residual disease and improving therapy decision-making to ultimately better patient outcomes in oncology.

Leadership Team

Laboratory Research and Development

Leadership Team

About

Team members

Other teams at Haystack Oncology

Laboratory Research and Development